JAK inhibitors appear to have a bright future in the treatment of atopic dermatitis
Br J Dermatol
.
2018 Feb;178(2):321.
doi: 10.1111/bjd.16227.
Author
R Bissonnette
1
Affiliation
1
Innovaderm Research Inc., 1851 Sherbrooke East Street, Suite 502, Montreal, QC, H2K 4L5, Canada.
PMID:
29441552
DOI:
10.1111/bjd.16227
No abstract available
Publication types
Comment
MeSH terms
Adult
Dermatitis, Atopic*
Eczema
Humans
Janus Kinase Inhibitors*
Pyrroles
Substances
Janus Kinase Inhibitors
Pyrroles
delgocitinib